Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1992: Drug Use Among DC Women Delivering Live Births in DC Hospitals (ICPSR 2347)
Alternate Title: DC*MADS, 1992 (Live Births)
Principal Investigator(s): United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
Summary: The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys.The DC*MADS: Drug Use Among Women Delivering Livebir... (more info)
This data is freely available.
United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse. Washington, DC, Metropolitan Area Drug Study (DC*MADS), 1992: Drug Use Among DC Women Delivering Live Births in DC Hospitals. ICPSR02347-v2. Ann Arbor, MI: Inter-university Consortium for Political and Social Research [distributor], 2008-12-15. doi:10.3886/ICPSR02347.v2
Persistent URL: http://dx.doi.org/10.3886/ICPSR02347.v2
This survey was funded by:
- United States Department of Health and Human Services. National Institutes of Health. National Institute on Drug Abuse
Scope of Study
The Washington, DC, Metropolitan Area Drug Study (DC*MADS) was conducted in 1991, and included special analyses of homeless and transient delivering live births in the DC hospitals. DC*MADS was undertaken to assess the full extent of the drug problem in one metropolitan area. The study was comprised of 16 separate studies that focused on different sub-groups, many of which are typically not included or are underrepresented in household surveys.
The DC*MADS: Drug Use Among Women Delivering Livebirths in DC Hospitals was designed to examine the nature and extent of drug use among women delivering live births in eight Washington, DC, hospitals participating in the study. Data from the questionnaires include prenatal care, health problems during pregnancy, pregnancy drug use history, needle use, polysubstance use, patterns of use, respondent's general experiences with drug use, including perceptions of the risks and consequences of use, occurrence of psychological and emotional problems, income and insurance coverage, treatment experiences, and maternal and infant outcomes. Medical records were abstracted from the women and their infants to document medical problems. Abstracted data on the mothers included demographics, discharge diagnoses, disposition at discharge, and results of urine screens. Abstracted data on infants included delivery information, status at discharge, discharge diagnoses/procedures, and first urine toxicology screen results.
Subject Terms: alcohol, alcohol consumption, cocaine, demographic characteristics, drug testing, drug use, drugs, hallucinogens, health care access, heroin, infants, inhalants, insurance coverage, live births, marijuana, mental health, population characteristics, pregnancy, prenatal care, reproductive history, sedatives, smoking, stimulants, substance abuse treatment, tobacco use, tranquilizers, urban population, women
Date of Collection:
Unit of Observation: individual
Universe: Women delivering live births in Washington, DC, hospitals.
Data Types: clinical data, survey data
Data Collection Notes:
To protect the anonymity of respondents, all variables that could be used to identify individuals have been encrypted, collapsed, or deleted. These modifications should not affect analytic uses of the data.
Produced by Research Triangle Institute in Research Triangle Park, NC.
Sample: Eight of nine Washington, DC, hospitals participated in the study. Eligible respondents were women delivering live births in participating hospitals during a given period. High-risk women, defined as those giving birth to low birth weight or pre-term infants or those admitting to drug use, were oversampled.
Mode of Data Collection: record abstracts, face-to-face interview
personal interviews and medical records
Response Rates: The interview response rate was 86.7 percent. Of those interviewed, 68.8 percent agreed to have medical records abstracted for themselves and their infants, resulting in an abstraction response rate of 59.7 percent.
Extent of Processing: ICPSR data undergo a confidentiality review and are altered when necessary to limit the risk of disclosure. ICPSR also routinely creates ready-to-go data files along with setups in the major statistical software formats as well as standard codebooks to accompany the data. In addition to these procedures, ICPSR performed the following processing steps for this data collection:
- Performed consistency checks.
- Created variable labels and/or value labels.
- Standardized missing values.
- Created online analysis version with question text.
- Performed recodes and/or calculated derived variables.
- Checked for undocumented or out-of-range codes.
Original ICPSR Release: 1998-04-28
- 2008-12-15 New files were added. These files included one or more of the following: Stata setup, SAS transport (CPORT), SPSS system, Stata system, SAS supplemental syntax, and Stata supplemental syntax files, and tab-delimited ASCII data file. Some other minor edits were made to improve the data and documentation.
- 2006-01-18 File CB2347.ALL.PDF was removed from any previous datasets and flagged as a study-level file, so that it will accompany all downloads.
- List all ~16 citations associated with this study
Most Recent Publications
Use any of the notification links to add this study to your RSS feed; you will then receive notification if the study is substantively updated.
- Citations exports are provided above.
Export Study-level metadata (does not include variable-level metadata)
If you're looking for collection-level metadata rather than an individual metadata record, please visit our Metadata Records page.